Price $56.40 |
Market Cap
1.1B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
111.2
|
P/B
6.57
|
P/S
24.63
|
Dividend %
0.40%
|
|
P/CF
28.5
|
P/FCF
163.7
|
Op. Cash Flow
10.9K
|
FCF
0.3
|
|
Op. Margin
27.20%
|
Net Margin
22.40%
|
ROE
13.20%
|
ROI
6.00%
|
|
ROA
11.40%
|
EPS Growth
6.80%
|
Current Ratio
23.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| STRATA Skin Sciences Inc (SSKN) | $1.63 | - | - | 56.7M | Strong Buy |
| Great Elm Capital Group Inc (GEC) | $2.60 | - | - | 71.8M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $2.33 | - | - | 62.4M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $9.41 | - | - | 10.73B | Strong Buy |
| Elite Pharmaceuticals Inc (ELTP) | $0.05 | - | - | 55.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
